Skip to Main Content

Paper Details

Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.
Cell Rep
3
2023
C-reactive protein, CD16CEACAM1/6/8, CD177, CD3CD4CEACAM1/6/8CD177CD63CD89, CD63, CD89, CEACAMs1, 6, and 8, COVID, COVID-19, CRP, CoV-2, D-dimer, PBMC, RNA, SARS, SARS-, SARS-CoV-, atypical CD3CD4CEACAM1, atypical CD3CD4CEACAM1/6/8CD177CD63CD89 and CD16CEACAM1/6/8 mononuclear cells, circulating immune cells, coronavirus 2, immune, immune populations, patient, patients, peripheral blood mononuclear cell, severe acute respiratory syndrome
Author NameAffiliation
Laura BergamaschiUniversity of Cambridge, UK Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre
Edward L HuttlinHarvard Medical School
Berthold GöttgensWellcome - MRC Cambridge Stem Cell Institute, University of Cambridge
John R BradleyUniversity of Cambridge, UK NIHR BioResource, Cambridge University Hospitals NHS Foundation
  • 1 - 4

Datasets

Release 1.2